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Case report 
A 52-year-old man who had never smoked was admitted to our hospital because of 
severe hypoxemia of unknown origin. He had a history of high fever (about 39°C) and 
dyspnea for several days. He had no prior history of lung disease and no exposure to 
occupational dust or animal hazards. The patient had no peripheral lymphadenopathy, 
no skin lesions, and no neurological deficits. On abdominal examination, the liver and 
spleen tip were not palpable. Laboratory examination showed an anaemia (Hb, 7.6 g/dl), 
a decreased platelet count (3.6×104/mm3), and a normal white blood cell count. The 
serum C-reactive protein (CRP) level was elevated (14.3 mg/dl), and the erythrocyte 
sedimentation rate was increased (24 mm/h). Other laboratory results included: total 
protein, 6.0 g/dl; serum albumin, 3.5 g/dl; serum creatinine, 1.4 mg/dl; blood urea 
nitrogen, 11.0 mg/dl; serum lactate dehydrogenase, 781 IU/l (markedly elevated); serum 
glucose concentration, normal; liver function tests, normal; and the serum complement 
prothrombin time was 53%. Arterial blood gases drawn on 4L O2 given nasally were: 
PaO2, 48.8 Torr; PaCO2, 31.8 Torr; pH, 7.48; HCO3, 24.1 mmol/L; BE 1.3 mmol/L. 
Antinuclear antibodies, rheumatoid factor, and antineutrophil cytoplasmic antibodies 
were not detected. Repeated blood, sputum, urine, and stool cultures were negative for 
possible pathogens. The urine was negative for Legionella antigen, and the Mycoplasma 
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pneumoniae antigen was negative. Chest radiography and high-resolution computed 
tomography (HRCT) were taken (Fig. 1A and Fig. 1B). Chest radiography on admission 
(Fig. 1A) showed slightly diffuse interstitial shadows in both lung fields. 
Chest HRCT revealed a bilateral ground-glass appearance involving predominantly the 
upper and middle lobes (Fig. 1B). An angio-CT scan showed no signs of pulmonary 
thromboembolism or lymphadenopathy in the chest and abdomen. There were no 
abnormalities on echocardiographic examination.  Bronchoscopy could not be done 
because of his hypoxemia and thrombocytopenia . The respiratory disturbance and 
pulmonary interstitial shadow progressed rapidly for several days from admission 
(Fig.2A and Fig.2B). Diffuse interstitial shadow progressed rapidly with pleural effusion 
on chest CT (Fig. 2C). 
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Clinical course 
Key words: intravascular lymphoma, interstitial shadow, early diagnosis 
Since the differential diagnosis initially included atypical pneumonia, AIP, and CVD, 
the patient was treated with antibiotics and steroid pulse therapy. His clinical status 
improved temporarily, and the diffuse interstitial infiltrates on both lung fields 
responded well to treatment with steroid pulse therapy (Fig. 2C), but he deteriorated 
when the steroid dose was reduced. His bicytopenia did not improve despite therapy. In 
order to characterize the blood disorder, bone marrow biopsy was performed, and many 
lymphoma cells were detected (Fig. 3). Flow cytometry studies demonstrated that the 
tumor cells were enhanced CD20-, CD5-, and CD22-positive B cells, and soluble IL-2 
receptor levels were very high (8701). In addition, the marrow cells showed 
monoclonality (99% sIgλ). Thus, based on the patient’s clinical characteristics and the 
immunohistochemical reactions, a diagnosis of pulmonary invasion of intravascular 
large B-cell lymphoma was made, and combination chemotherapy was begun. After 
combined chemotherapy clinical symptoms, laboratory and radiological findings were 
markedly improved. 
The initial differential diagnosis of this patient included atypical pneumonia, AIP, 
CVD, drug-induced pneumonia, and lymphoproliferative disease since the patient 
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responded to steroid therapy temporarily. Furthermore, the diffuse interstitial shadows 
in both lung fields deteriorated while steroid therapy was tapered. The patient was 
finally diagnosed as having diffuse large B-cell lymphoma based on bone marrow 
biopsy, and the fact that steroid therapy had a temporary effect suggests that the 
hypoxemia and the radiological changes were caused by lymphoma, since lymphoma is 
well known to be sensitive to steroid therapy. This type of lymphoma includes 
pyothorax-related lymphoma, mediastinal large cell lymphoma, and intravascular large 
cell lymphoma; it accounts for half of adult non-Hodgkin lymphoma cases. In the 
present case, there was no lymph node swelling, but the patient presented with a high 
fever, acute dyspnea, and bicytopenia  Although the patient was given antibiotics no 
improvement was seen. There was no evidence of a clear focus of lymphoma other than 
the lung infiltration, so that a diagnosis of intravascular large B-cell lymphoma (IVL) 
was made. IVL is a rare, distinctive form of malignant lymphoma, and accounts for ≤ 
1% of adult non-Hodgkin lymphoma cases［1］. It has been previously reported that IVL 
is characterized by CNS and skin lesions and is not accompanied by lymph node 
enlargement［2］. It is difficult to make an early diagnosis since the tumour grows 
primarily in small arteries, small veins, and capillary vessels, without enlarged lymph 
nodes or tumour formation. But recent reports have suggested that complete remission 
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and long-term disease-free survival may be achieved with early therapeutic intervention 
［3］. One of the particular aspects of this case is chest radiographic manifestation. 
Although IVL is frequently found in the lung at autopsy, there are a few reports about 
pulmonary manifestation. The majority of cases with lung involvement showed diffuse 
interstitial infiltrates on chest radiographs ［4-9］(Table1). The mechanism of this 
radiographic change and hypoxemia in the present case was assumed to be the result of 
diffuse invasion of lymphoma cells into pulmonary small vessels, resulting in a 
ventilation-perfusion mismatch due to lymphoma cell accumulation within the 
pulmonary blood vessels, as well as a diffusion disturbance due to invasion of 
lymphoma cells into the pulmonary interstitial space. Especially, lung pathologic lesion, 
respiratory disturbance and rapidly progressive clinical course were frequently shown in 
AIVL. The patient in this case presented with bicytopenia and rapid deterioration of the 
respiratory symptoms but not CNS and skin lesions; such a clinical course is similar to 
that described for AIVL, which has been reported in many Asian countries, including 
Japan［10］. In the present case, diffuse ground glass opacity with septal thicking and 
perivascular spaces on high resolution (HR) CT was seen. Yamagata et al. reported that 
almost 75 % of 16 cases of IVL pulmonary involvement showed diffuse pulmonary 
shadow such as bilateral reticular shadow, reticulonodular shadow, ground-glass opacity
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［11］. There are a few reports about the lung radiograpfic manifestations of IVL, so the 
analysis and accumulation of radiologic information about IVL may be able to play an 
important role in leading to a prompt diagnosis and an appropriate therapy for 
clinicians.  
In conclusion, IVL should be suspected in patients with a fever of unknown origin, 
hypoxaemia, and a high LDH level. Even though IVL is a blood disorder, patients may 
present with a clinical picture suggestive of pneumonia, as in the present case. Thus, in 
patients with pneumonia who do not respond to antibacterial therapy but have an 
atypical clinical course with diffuse ground glass opacity on high resolution (HR) CT, it 
is important to consider the possibility of IVL early to improve the mortality rate.  
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Figure legend 
Fig.1A  
Chest radiography on admission showed slightly diffuse interstitial shadows in both 
lung fields. 
Fig.1B  
Chest high-resolution computed topography (HRCT) on admission revealed a bilateral 
ground-glass appearance involving predominantly the upper and middle lobes.  
Fig.2A 
Chest radiography after 6days from admission showed diffuse interstitial shadow 
progressed rapidly on chest radiography.  
Fig.2B 
Chest CT after 6days from admission showed diffuse interstitial shadow progressed 
rapidly with pleural effusion. 
Fig.2C 
The infiltrations on both lung fields were improved after steroid pulse therapy 
Fig.3. 
Bone marrow biopsy was performed. Microscopically, the numerous neoplastic cells 
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Nakamura et al 
(current report)
surviveHigh fever, dyspnea bilateral ground‐glass opacity with subpleural predominance 
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Table 1 previous intravascular lympho,a cases with interstitial shadow 
